These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32525153)

  • 21. Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.
    Paterson BM; Donnelly PS
    Chem Soc Rev; 2011 May; 40(5):3005-18. PubMed ID: 21409228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azaindoles: Suitable ligands of cytotoxic transition metal complexes.
    Štarha P; Trávníček Z
    J Inorg Biochem; 2019 Aug; 197():110695. PubMed ID: 31054487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondria as a target of third row transition metal-based anticancer complexes.
    Olelewe C; Awuah SG
    Curr Opin Chem Biol; 2023 Feb; 72():102235. PubMed ID: 36516614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.
    Giorgi E; Binacchi F; Marotta C; Cirri D; Gabbiani C; Pratesi A
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porphyrin complexes of the period 6 main group and late transition metals.
    Lemon CM; Brothers PJ; Boitrel B
    Dalton Trans; 2011 Jul; 40(25):6591-609. PubMed ID: 21384031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
    Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Good Fashion is Evolution, Not Revolution" - Methods to Enhance Existing Anticancer Medicines, Primarily with the Use of Transition Metal.
    Guzowska M; Kalinowska M; Lewandowski W
    Anticancer Agents Med Chem; 2018; 18(4):476-487. PubMed ID: 29189181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in cancer treatment by iron chelators.
    Corcé V; Gouin SG; Renaud S; Gaboriau F; Deniaud D
    Bioorg Med Chem Lett; 2016 Jan; 26(2):251-256. PubMed ID: 26684852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.
    Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang ML; Lane DJR; Lok H; Richardson DR
    Curr Med Chem; 2019; 26(2):302-322. PubMed ID: 28685681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
    Robert A; Liu Y; Nguyen M; Meunier B
    Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment.
    Kontoghiorghes GJ; Efstathiou A; Ioannou-Loucaides S; Kolnagou A
    Hemoglobin; 2008; 32(1-2):217-27. PubMed ID: 18274999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modifications of boronic ester pro-chelators triggered by hydrogen peroxide tune reactivity to inhibit metal-promoted oxidative stress.
    Charkoudian LK; Pham DM; Kwon AM; Vangeloff AD; Franz KJ
    Dalton Trans; 2007 Nov; (43):5031-42. PubMed ID: 17992288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on transition metal-quercetin complexes using electrospray ionization tandem mass spectrometry.
    Liu Y; Guo M
    Molecules; 2015 May; 20(5):8583-94. PubMed ID: 25985359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.
    Palermo G; Magistrato A; Riedel T; von Erlach T; Davey CA; Dyson PJ; Rothlisberger U
    ChemMedChem; 2016 Jun; 11(12):1199-210. PubMed ID: 26634638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
    Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
    Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition Metal-Based Prodrugs for Anticancer Drug Delivery.
    Phillips AMF; Pombeiro AJL
    Curr Med Chem; 2019; 26(41):7476-7519. PubMed ID: 30501593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The medicinal chemistry of novel iron chelators for the treatment of cancer.
    Kovacevic Z; Kalinowski DS; Lovejoy DB; Yu Y; Suryo Rahmanto Y; Sharpe PC; Bernhardt PV; Richardson DR
    Curr Top Med Chem; 2011; 11(5):483-99. PubMed ID: 21192781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.
    Yu Y; Wong J; Lovejoy DB; Kalinowski DS; Richardson DR
    Clin Cancer Res; 2006 Dec; 12(23):6876-83. PubMed ID: 17145804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress and future potential for metal complexes as anticancer drugs targeting G-quadruplex DNA.
    Zhang J; Zhang F; Li H; Liu C; Xia J; Ma L; Chu W; Zhang Z; Chen C; Li S; Wang S
    Curr Med Chem; 2012; 19(18):2957-75. PubMed ID: 22519400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.